Clinical Trial Update: Study of Stereotactic Ablative Radiotherapy(SBRT) Followed by Atezolizumab / Tiragolumab in Treatment-naive Patients With Metastatic Non-small Cell Lung Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating SBRT followed by atezolizumab/tiragolumab in treatment-naive metastatic non-small cell lung cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Yonsei University | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: UNKNOWN